Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration
NCT ID: NCT02860195
Last Updated: 2017-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2016-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One of possible application would be a continuous and non invasive monitoring of drinking behavior. To investigate the validity of this method, it's necessary to compare Transdermal Alcohol Concentrations results obtained by this new device with Blood Alcohol Concentrations and breath Alcohol Concentrations provided by reference methods.
The purpose of this study is to identify the kinetic of alcohol concentration in blood, exhaled air and sweat after alcohol ingestion.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy volunteers
oral dose of alcohol
alcotest
blood samples
Transdermal monitor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral dose of alcohol
alcotest
blood samples
Transdermal monitor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian
* BMI: 19 to 28 kg/m2
* No smoking or light smoker (\<5 cig/d)
* Moderate consumer of alcohol (3-14 drinks/week), with the intoxicated experience
Exclusion Criteria
* Positive individuals in search of drugs and toxic
* Anxiety or depressive subjects (IASTA Questionnaires and BDI)
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine GEINDRE
Role: STUDY_DIRECTOR
Assistance Publique Hopitaux De Marseille
OLIVIER BLIN
Role: PRINCIPAL_INVESTIGATOR
ASSISTANCE PUBLQIUE HOPITAUX DE MARSEILLE
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00729-42
Identifier Type: REGISTRY
Identifier Source: secondary_id
2016-12
Identifier Type: -
Identifier Source: org_study_id